Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access
Login for full access:
Concurrent Session 4: Targeting the Innate Immune System
- Sort by:
- Browse by:
- Paid users only
- purchase
- Available
- Some slides withheld
Integrating anti-GD2 therapies and fusokines with NK cells for pediatric solid tumors
Christian M Capitini
University of Wisconsin, Madison, WI, United States
- Permission not
granted for presentation
Genetically Engineered Natural Killer Cell Lines For Treatment of Cancer
Hans Klingemann
NantKwest, Inc., Woburn, MA, United States
- Paid users only
- purchase
- Available
- Some slides withheld
Exploring Approaches to Optimize NK Cell-Based Immunotherapy for Cancer
Richard W Childs
National Heart, Lung, and Blood Institute, Bethesda, MD, United States